Altria Group Inc
NYSE: MO
$53.54
-$0.75 (-1.4%)
Closing Price on November 7, 2024
MO Articles
Philip Morris reported earnings and revenues that beat second-quarter estimates. Recent FDA approval of the company's IQOS products have boosted share prices as well.
Published:
Marijuana stocks have suffered a terrible beating in the past year or so. Here's a look at six former high-flyers and their prospects for a recovery.
Published:
Wednesday's top analyst upgrades and downgrades included Altria, Apple, Caterpillar, Citigroup, JPMorgan, Nikola, Nokia, Novavax, Transocean, Valero Energy, Walt Disney and Wells Fargo.
Published:
If investors have learned one thing over time, it is that it can be very painful when a company announces that it is cutting its dividend. 24/7 Wall St. has screened out 10 stocks that have dividends...
Published:
With new e-cigarette lawsuits, Juul is anything but the jewel in the Altria crown.
Published:
Altria’s attempts to diversify have soured and its stock is lagging, but the company has pricing power and pays a solid dividend.
Published:
Counting out a tobacco company has never proved to be a good bet over the long term. Will this time be different?
Published:
Cigarette smoking is falling out of favor but Altria could still appeal to investors as it looks to tobacco alternatives.
Published:
Altria wants to diversify into e-cigarettes and legal pot, but faces regulatory action, patent litigation and coronavirus-related setbacks.
Published:
U.K. tobacco giant Imperial Brands has slashed its dividend. Will American tobacco companies follow suit?
Published:
Last Updated:
When the economy began to face an instant recession from the coronavirus, even before the name COVID-19 became labeled a pandemic, the phenomena of buying defensive stocks was thrown out the window....
Published:
Altria's share price is falling. Its investments have been busts, and hedge funds and shareholders are getting cranky. Even the dividend hasn't made investors happy.
Published:
Altria’s investments in Juul and Cronos Group weigh on investor sentiment even though core tobacco business looks strong.
Published:
COVID-19 has already beaten up tobacco giant Altria but things may be getting even worse as Juul, in which it has a stake, is facing fresh problems.
Published:
Altria Group Inc. investors will want to note the latest setbacks for e-cigarette manufacturer Juul Labs, which include regulatory troubles, adverse publicity around the health effects of vaping, and...
Published: